CN102657750A - Chinese medicinal composition for treating urinary tract infection - Google Patents

Chinese medicinal composition for treating urinary tract infection Download PDF

Info

Publication number
CN102657750A
CN102657750A CN2012101415385A CN201210141538A CN102657750A CN 102657750 A CN102657750 A CN 102657750A CN 2012101415385 A CN2012101415385 A CN 2012101415385A CN 201210141538 A CN201210141538 A CN 201210141538A CN 102657750 A CN102657750 A CN 102657750A
Authority
CN
China
Prior art keywords
parts
chinese
urinary tract
medicinal composition
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012101415385A
Other languages
Chinese (zh)
Other versions
CN102657750B (en
Inventor
林荣波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningguo Jisi Intellectual Property Operation Co ltd
Original Assignee
Rongcheng Shangmaocheng Health Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rongcheng Shangmaocheng Health Center filed Critical Rongcheng Shangmaocheng Health Center
Priority to CN201210141538.5A priority Critical patent/CN102657750B/en
Publication of CN102657750A publication Critical patent/CN102657750A/en
Application granted granted Critical
Publication of CN102657750B publication Critical patent/CN102657750B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the technical field of Chinese medicaments, and aims to provide a Chinese medicinal composition with scientific and simple compatibility and good curative effect according to the cognition mechanism of Chinese medicine on urinary tract infection. The Chinese medicinal composition consists of the following Chinese herbal medicines in part by weight: 18 to 22 parts of morinda officinalis, 28 to 32 parts of dipsacus root, 18 to 22 parts of dandelion, 12 to 18 parts of acorus gramineus, 12 to 18 parts of atractylodes, 12 to 18 parts of big-head atractylodes rhizome, 12 to 18 parts of weeping forsythia, 28 to 32 parts of sow thistle, 12 to 18 parts of plantain seed, 12 to 18 parts of dianthus superbus, 12 to 18 parts of polygonum aviculare, 9 to 15 parts of gardenia, and 8 to 12 parts of liquorice. The invention has the advantages that the Chinese medicinal composition is definite in curative effect, does not have obvious adverse reaction, and is good in application compliance of patients and beneficial to treatment and consolidation of diseases.

Description

A kind of Chinese medicine composition of treating urinary tract infection
 
Technical field
The invention belongs to technical field of Chinese medicines, specifically be meant a kind of Chinese medicine composition of treating urinary tract infection.
Background technology
Urinary tract infection is called for short the urine sense, is meant the urinary tract inflammation that pathogen infringement urinary tract mucosa or tissue cause.According to infection site, urinary tract infection can be divided into upper urinary tract infection and lower urinary tract infection, and the former is a pyelonephritis, and the latter is mainly cystitis.
The traditional Chinese medical science to the understanding of urinary tract infection one disease is: the cause of disease of primary disease with damp and hot be main, sick position is at bladder and kidney, and relevant with liver spleen etc.Its pathogenesis mainly is the damp-heat accumulation part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, and the mechanism of qi that is jammed causes functioning of bladder unfavorable, if with the passing of time disease prolongs damp and hot also can fumigating in kidney, gas the moon that consumption is impairment of the kidney.
Summary of the invention
The objective of the invention is provides the Chinese medicine composition of simple, eutherapeutic this disease of treatment of a kind of compatibility science according to the understanding mechanism of the traditional Chinese medical science to urinary tract infection one disease.
For realizing above-mentioned technical purpose; The technical scheme that the present invention adopts is: a kind of Chinese medicine composition of treating urinary tract infection is characterized in that: this Chinese medicine composition is to adopt following materials of weight proportions drug regimen to form: Radix Morindae Officinalis 18-22, Radix Dipsaci 28-32, Herba Taraxaci 18-22, Rhizoma Acori Graminei 12-18, Rhizoma Atractylodis 12-18, Rhizoma Atractylodis Macrocephalae 12-18, Fructus Forsythiae 12-18, Herba Ixeritis chinensis 28-32, Semen Plantaginis 12-18, Herba Dianthi 12-18 、 Herba Polygoni Avicularis 12-18, SHANZHIZI 9-15, Radix Glycyrrhizae 8-12.
The instructions of taking of this Chinese medicine composition is: after the material medicine of aforementioned proportion is mixed, adopt the method for traditional fried Chinese medicine to get its medicine juice, every pair 350-500ml that takes concoction divides sooner or later and takes for twice, every day one pair.
What effect diarrhea Jiao of the relieving stranguria by diuresis of ， Qu Herba Polygoni Avicularis, Herba Dianthi, Semen Plantaginis, tonneau bladder pented up in Chinese medicine composition provided by the present invention is damp and hot; Get Rhizoma Acori Graminei, Rhizoma Atractylodis, Rhizoma Atractylodis Macrocephalae removing dampness appetizing, invigorating the spleen and benefiting QI; Get Fructus Forsythiae, Herba Ixeritis chinensis, SHANZHIZI and carry out heat-clearing and toxic substances removing; For damp and hot the letting out too down that prevents the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels injures Liver and kidney, utilized Radix Morindae Officinalis, Radix Dipsaci to carry out invigorating the liver and kidney, bone and muscle strengthening in the Chinese medicine composition provided by the invention again, benefit is arranged thereby reach in letting out.Through strengthening the spleen and stomach, let out damp and hotly, recover the gasification function of bladder, thereby reach the technical purpose of treatment urinary tract infection.
Beneficial effect of the present invention is: curative effect is sure, no obvious adverse reaction, and it is good that the patient uses compliance, is beneficial to treatment of diseases, consolidation.
The specific embodiment
Below in conjunction with embodiment and practical situation the present invention is further specified.
According to prescription requirement of the present invention, in 20 parts of weight portion proportioning Radix Morindae Officinaliss, 30 parts of Radix Dipsaci, 20 parts of Herba Taraxacis, 15 parts of Rhizoma Acori Graminei, 15 parts of Rhizoma Atractylodis, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Fructus Forsythiaes, 30 parts of Herba Ixeritis chinensiss, 15 parts of Semen Plantaginiss, Herba Dianthi 15 15 parts of Fen 、 Herba Polygoni Avicularis, 12 parts of SHANZHIZI, 10 parts in Radix Glycyrrhizae.
1, alternative
1.1 diagnostic criteria: comprise that bladder irritations such as frequent micturition, urgent micturition, dysurea levy, lumbago with
(or) hypogastric region pain, sometimes with shiver with cold, heating, headache, feel sick, vomiting,
Symptoms such as inappetence; Centrifugal back urinary sediment microscopy leukocyte>5/HP)+experiment of urine nitrite is positive, meets the urinary tract infection symptom.
Include the rated age at 22 years old-63 years old.
1.2 be divided into treatment by Chinese herbs group and western medicine group at random, treatment by Chinese herbs group 38 examples, age 35-63 year, mean age (49.67 ± 4.21 years old), the course of disease 1.40 ± 0.88 years; Western medicine group 13 examples, age 22-50 year, mean age (38.52 ± 1.02 years old), the course of disease 1.68 ± 1.02 years.
2. method
2.1 medicine
Chinese medicine preparation Radix Morindae Officinalis 20g, Radix Dipsaci 30g, Herba Taraxaci 20g, Rhizoma Acori Graminei 15g, Rhizoma Atractylodis 15g, Rhizoma Atractylodis Macrocephalae 15g, Fructus Forsythiae 15g, Herba Ixeritis chinensis 30g, Semen Plantaginis 15g, Herba Dianthi 15g 、 Herba Polygoni Avicularis 15g, SHANZHIZI 12g, Radix Glycyrrhizae 10g are as a pair.Western medicine levofloxacin injection+nitrofurantoin.
2.2 Therapeutic Method
The treatment by Chinese herbs group: get Chinese medicine composition provided by the invention, every day one, pair took its medicine juice, and take for twice every day sooner or later, and 7 is a course of treatment.
The western medicine group: levofloxacin injection 300mg every day, twice intravenous drip+nitrofurantoin was 0.1g/ time, 4 times/day.
2.3 observation item
The change of state of an illness symptom and centrifugal back urinary sediment microscopy quantity of leucocyte, turning out cloudy property of urine nitrite experiment before and after the treatment.
The result:
? The example number Therapeutic outcome on the 7th Therapeutic outcome on the 14th Therapeutic outcome on the 21st Recurrence half a year statistics
The treatment by Chinese herbs group 38 Physical symptoms such as the whole urine urgency-frequencies of 38 examples greatly alleviate, and the centrifugal back of 28 examples urinary sediment microscopy leukocyte＜5/HP), 21 example urine nitrites are tested negative. 32 examples all physical symptom such as urine urgency-frequencies disappear, and wherein the centrifugal back of 30 examples urinary sediment microscopy leukocyte＜5/HP), the nitrite experiment is negative. In 38 examples 36 examples all physical symptom such as urine urgency-frequencies disappear, centrifugal back urinary sediment microscopy leukocyte＜5/HP), the nitrite experiment is negative, reaches the rehabilitation standard; 2 routine doing well,improvings, centrifugal back urinary sediment microscopy quantity of leucocyte reduces, but still is higher than 5/HP, and nitrite is tested 1 example and is turned out cloudy, and 1 example is still positive 36 routine rehabilitation patients do not see recurrence.
The western medicine group 13 Physical symptoms such as 5 routine urine urgency-frequencies improve, and the centrifugal back of 2 examples urinary sediment microscopy leukocyte＜5/HP), 1 example urine nitrite experiment is negative. Physical symptoms such as 8 routine urine urgency-frequencies disappear, and the centrifugal back of 5 examples urinary sediment microscopy leukocyte＜5/HP), the nitrite experiment is negative. Physical symptoms such as 9 routine urine urgency-frequencies disappear, and centrifugal back urinary sediment microscopy leukocyte＜5/HP), the nitrite experiment is negative; The centrifugal back of 2 examples urinary sediment microscopy leukocyte＜5/HP), but the nitrite experiment is positive; The centrifugal back of 2 examples urinary sediment microscopy leukocyte＞5/HP), the nitrite experiment is positive; 7 example recurrences need be treated once more in 9 examples.
Can find out relatively that through The above results this Chinese medicine composition of employing obviously is superior to the treatment of Western medicine to this disease to the therapeutic effect of urinary tract infection one disease, and treatment by Chinese herbs has the advantage of instant effect, difficult recurrence.
Each the raw material Chinese medicinal components that in this embodiment, provides, this Chinese medicine composition can also adopt following component to carry out prescription:
1,18 parts of Radix Morindae Officinaliss, 32 parts of Radix Dipsaci, 18 parts of Herba Taraxacis, 18 parts of Rhizoma Acori Graminei, grey
12 parts of arts, 18 parts of the Rhizoma Atractylodis Macrocephalaes, 12 parts of Fructus Forsythiaes, 32 parts of Herba Ixeritis chinensiss, 12 parts of Semen Plantaginiss, Herba Dianthi 18 12 parts of Fen 、 Herba Polygoni Avicularis, 15 parts of SHANZHIZI, 8 parts in Radix Glycyrrhizae.
2,22 parts of Radix Morindae Officinaliss, 28 parts of Radix Dipsaci, 22 parts of Herba Taraxacis, 12 parts of Rhizoma Acori Graminei, 18 parts of Rhizoma Atractylodis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 18 parts of Fructus Forsythiaes, 28 parts of Herba Ixeritis chinensiss, 18 parts of Semen Plantaginiss, Herba Dianthi 12 18 parts of Fen 、 Herba Polygoni Avicularis, 9 parts of SHANZHIZI, 12 parts in Radix Glycyrrhizae.

Claims (1)

1. Chinese medicine composition of treating urinary tract infection is characterized in that: this Chinese medicine composition is to adopt following materials of weight proportions drug regimen to form: Radix Morindae Officinalis 18-22, Radix Dipsaci 28-32, Herba Taraxaci 18-22, Rhizoma Acori Graminei 12-18, Rhizoma Atractylodis 12-18, Rhizoma Atractylodis Macrocephalae 12-18, Fructus Forsythiae 12-18, Herba Ixeritis chinensis 28-32, Semen Plantaginis 12-18, Herba Dianthi 12-18, Herba Polygoni Avicularis 12-18, SHANZHIZI 9-15, Radix Glycyrrhizae 8-12.
CN201210141538.5A 2012-05-09 2012-05-09 Chinese medicinal composition for treating urinary tract infection Expired - Fee Related CN102657750B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210141538.5A CN102657750B (en) 2012-05-09 2012-05-09 Chinese medicinal composition for treating urinary tract infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210141538.5A CN102657750B (en) 2012-05-09 2012-05-09 Chinese medicinal composition for treating urinary tract infection

Publications (2)

Publication Number Publication Date
CN102657750A true CN102657750A (en) 2012-09-12
CN102657750B CN102657750B (en) 2014-08-13

Family

ID=46767418

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210141538.5A Expired - Fee Related CN102657750B (en) 2012-05-09 2012-05-09 Chinese medicinal composition for treating urinary tract infection

Country Status (1)

Country Link
CN (1) CN102657750B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101152472A (en) * 2007-09-17 2008-04-02 尹克山 Traditional Chinese medicine for treating pregnancy complicated with urinary tract infection

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101152472A (en) * 2007-09-17 2008-04-02 尹克山 Traditional Chinese medicine for treating pregnancy complicated with urinary tract infection

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
杨宗善: "尿路感染的中医药治疗概况", 《陕西中医》 *
林海峰: "中医药治疗非淋菌性尿道炎研究概况", 《广西中医学院学报》 *

Also Published As

Publication number Publication date
CN102657750B (en) 2014-08-13

Similar Documents

Publication Publication Date Title
CN103330865B (en) Medicine for curing non-alcoholic steatohepatitis and preparation method thereof
CN103690741A (en) Pharmaceutical composition for treating gout and gouty arthritis
CN103127422B (en) Medicament for treating ulcerative colitis
CN103705689A (en) Drug composition for treating gout and gouty arthritis
CN104027517A (en) Traditional Chinese medicine for treating acute enteritis
CN103690710A (en) Pharmaceutical composition for treating gout and gouty arthritis
CN104288496A (en) Traditional Chinese medicine composition for treating constipation
CN101804189B (en) Drug for treating primary dysmenorrhea
CN101757206A (en) Chinese medicine preparation for treating chronic colitis
CN103550715A (en) Traditional Chinese medicine for treating bronchitis
CN102657750B (en) Chinese medicinal composition for treating urinary tract infection
CN103142839B (en) A kind of Chinese medicinal formulae for the treatment of impotence and premature ejaculation
CN104258275A (en) Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis
CN104840927A (en) Traditional Chinese medicine for treating chronic erosive gastritis
CN103690744A (en) Pharmaceutical composition for treating gout and gouty arthritis
CN102824460A (en) Medicine for treating urticaria
CN103099855B (en) Traditional Chinese medicine (TCM) pill for treating irritable bowel syndrome
CN102949684B (en) Medicine formula for treating rheumatoid arthritis
CN102743652B (en) Chinese medicinal preparation for treating male infertility
CN102379965A (en) Traditional Chinese medicine for treating chronic prostatitis
CN101884747B (en) Traditional Chinese medicine for treating chronic nephritis
CN101417109A (en) Medicine for treating bed-wetting and urinary incontinence
CN105267942A (en) Traditional Chinese medicine for treating liver-qi-spleen-restricting type diarrhoea
CN104189624A (en) Traditional Chinese medicine for treating pelvic inflammation
CN105232609A (en) Traditional Chinese medicine combination treating functional dyspepsia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: LIU RONGFEN

Free format text: FORMER OWNER: RONGCHENG SHANGMAOCHENG HEALTH CENTER

Effective date: 20140609

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Liu Rongfen

Inventor after: Zhao Yan

Inventor after: Zhang Xiaoling

Inventor after: Lin Rongbo

Inventor before: Lin Rongbo

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LIN RONGBO TO: LIU RONGFEN ZHAO YAN ZHANG XIAOLING LIN RONGBO

Free format text: CORRECT: ADDRESS; FROM: 264300 WEIHAI, SHANDONG PROVINCE TO: 264200 WEIHAI, SHANDONG PROVINCE

TA01 Transfer of patent application right

Effective date of registration: 20140609

Address after: 264200, Rongcheng, Shandong province Weihai city Shidao Management Zone double Bang East Road No. 199

Applicant after: Liu Rongfen

Address before: 264300 Health Center, Rongcheng Trade Center, Weihai, Shandong

Applicant before: Rongcheng Trade City Health Center

ASS Succession or assignment of patent right

Owner name: ZHANG SHUWEN

Free format text: FORMER OWNER: LIU RONGFEN

Effective date: 20140703

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Zhang Shuwen

Inventor after: Liu Rongfen

Inventor before: Liu Rongfen

Inventor before: Zhao Yan

Inventor before: Zhang Xiaoling

Inventor before: Lin Rongbo

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LIU RONGFEN ZHAO YAN ZHANG XIAOLING LIN RONGBO TO: ZHANG SHUWEN LIU RONGFEN

TA01 Transfer of patent application right

Effective date of registration: 20140703

Address after: 264200, room 31, building No. 403, lotus pond south, Rongcheng, Shandong, Weihai

Applicant after: Zhang Shuwen

Address before: 264200, Rongcheng, Shandong province Weihai city Shidao Management Zone double Bang East Road No. 199

Applicant before: Liu Rongfen

C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20151229

Address after: 637400, No. 2, building 2, building 4, 2, East Temple, 8 East Street, Shoushan temple, Nanchong, Sichuan, Langzhong

Patentee after: Wang Lihua

Address before: 264200, room 31, building No. 403, lotus pond south, Rongcheng, Shandong, Weihai

Patentee before: Zhang Shuwen

C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: 225300 Taizhou science and Technology Park, Jiangsu high tech Park revitalization Avenue, No. 197

Patentee after: Wang Lihua

Address before: 637400, No. 2, building 2, building 4, 2, East Temple, 8 East Street, Shoushan temple, Nanchong, Sichuan, Langzhong

Patentee before: Wang Lihua

TR01 Transfer of patent right

Effective date of registration: 20190923

Address after: Room 501, Office Building of Market Supervision Bureau of Langchuan Avenue, Jianping Town, Langxi County, Xuancheng City, Anhui Province

Patentee after: Xuancheng Geith Intellectual Property Operations Co.,Ltd.

Address before: 225300 Taizhou science and Technology Park, Jiangsu high tech Park revitalization Avenue, No. 197

Patentee before: Wang Lihua

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20201201

Address after: Ji'an City, Jiangxi province 343900 area Suichuan County Yunling industry

Patentee after: JIANGXI SUICHUAN LIGHT VELOCITY ELECTRONIC Co.,Ltd.

Address before: Room 501, Office Building of Market Supervision Bureau of Langchuan Avenue, Jianping Town, Langxi County, Xuancheng City, Anhui Province

Patentee before: Xuancheng Geith Intellectual Property Operations Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20201217

Address after: Room 303, 3rd floor, West, building 16, electronic information industrial park, heli Park, Ningguo Economic and Technological Development Zone, Xuancheng City, Anhui Province

Patentee after: Ningguo Jisi Intellectual Property Operation Co.,Ltd.

Address before: 343900 Yunling industrial concentration area, Suichuan County, Ji'an, Jiangxi

Patentee before: JIANGXI SUICHUAN LIGHT VELOCITY ELECTRONIC Co.,Ltd.

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140813